Diabetes

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.

Listed below are members of the Clinical Oversight Committee and Working Groups who participated in development of the Clinical Guidelines for Joslin Diabetes Center. Faculty who participated in guideline development who are no longer at Joslin are designated with an asterisk.

Om P. Ganda, MD, serves as chair of the Joslin Clinical Oversight Committee, and Robert A. Gabbay, MD, PhD, FACP, is senior vice president and chief medical officer of Joslin Diabetes Center.

This week in managed care, the top stories included Atul Gawande, MD, being named the CEO of the Amazon–Berkshire Hathaway–JPMorgan Chase healthcare venture; the Trump administration finalized rules for creating association health plans; an analysis found some cancer types are represented more than others in the Oncology Care Model.

FDA action; gene discover in ALL

The guidance from the American College of Physicians continues to drive debate on how to care for adults with diabetes.

While receiving a diagnosis of type 2 diabetes is common for US adults, African American and Latino adults over age 50 who receive a new diabetes diagnosis may have another health issue to be concerned about: pancreatic cancer.

If you heard of a drug with a 387 percent return on investment, wouldn’t you want in? That was the result of a voluntary program in Maine that provided proper meals to high-risk Medicare patients leaving the hospital. Managed Care Cast explores results that appear in the current issue ofThe American Journal of Managed Care®.

The survey found that the real cost of living with diabetes goes beyond what people spend out of pocket, and includes the toll the disease takes on relationships, work, and outside interests.

The authors say there has been a recent uptick in hosptial admissions from hypoglycemic events, and that a therapy to address this is needed.

Health plans are under scrutiny to address social determinants of health, which include food insecurity and poor housing.

The ban on letting people in Medicare connect their continuous glucose monitor (CGM) to a smartphone drew ire from patients, advocates, and even the Government Accountability Office.

The prevalence and predictors of hypoglycemia in South Korean patients with type 2 diabetes were evaluated using a nationwide healthcare database.

Nearly two-thirds of those participating in the study reported feelings of stigma from having to manage type 1 diabetes.

The authors speculated that some cancer regimens, such as those with corticosteroids, cause hyperglycemia.

Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

The top status comes as digital providers, such as Omada Health, are trying to convince CMS to include them in the Medicare National Diabetes Prevention Program program.

This week, the top managed care stories include Senator Bill Cassidy's new plan to lower healthcare costs; policy recommendations from the American Diabetes Association on how to lower insulin prices; and coverage from the American Society of Clinical Oncology annual meeting.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

The results support other evidence that suggests the link between irregular eating patterns and diabetes is distinctly different from the one that drives obesity.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories include the finding that new guidelines will mean the number of people with hypertension will soar; research finds that most diabetes apps don’t lower glycated hemoglobin; and a health plan announced its plan to fight housing instability.

The American Diabetes Association (ADA) released a set of policy recommendations designed to spotlight the increasing difficulties patients with diabetes have affording insulin or gaining access to the life-saving medication. The recommendations follow the findings of a working group about the issue, the findings of which were presented to the Special Senate Committee on Aging earlier this month.

The American Diabetes Association (ADA) released a set of policy recommendations designed to spotlight the increasing difficulties patients with diabetes have affording insulin or gaining access to the life-saving medication. The recommendations follow the findings of a working group about the issue, the findings of which were presented to the Special Senate Committee on Aging earlier this month.

Clinical trial data has shown that the drug helped 28.6% of patients achieve glycated hemoglobin of 7.0% of less by week 24 without severe hypoglycemia or diabetic ketoacidosis and also helped participants lose weight.

The health hazards of workplace wellness programs fall within 6 categories.

The study comes as FDA is moving to bring more order to the area of mobile health. It is in the midst of a pilot for a precertifcation process that involves well-known companies such as Apple, Verily, and diabetes-specific companies like Tidepool.

Approximately 20% of patients with epilepsy have a co-occurring autoimmune disorder, and autoantibodies directed against the smaller isoform of glutamate decarboxylase (GAD65Ab) have been found in patients with epilepsy, as well as in patients with stiff person syndrome and type 1 diabetes.